FLUPHENAZINE (ORAL) vs RISPERIDONE
Quality of life (long term) ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
- Fluphenazine (oral) versus atypical antipsychotics for schizophrenia 2016 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found